Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for Preventing Alcohol Withdrawal Syndrome
NCT02052440Phase 3Terminated
- Sponsor
- Denver Health
- Start
- Mar 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baclofen in alcohol withdrawal syndrome (AWS), sponsored by Denver Health. Started Mar 2014; status: terminated.
02
Drugs
baclofen
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT02052440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052440.